Treatment may prevent Alzheimer's cognitive decline

A new study in mice found that a treatment involving antibodies to Dkk1, a protein linked to amyloid formation in Alzheimer's patients, may protect memory by stopping the disintegration of brain synapses. It won't be useful in people who already have advanced Alzheimer's disease but could potentially slow the rate of cognitive deterioration in those in the early stages of the disease.

View Full Article in:

Independent (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC